⌘K

Login Start Free

Home/Filings/4/0001501697-25-000035

4//SEC Filing

Craig Adam R 4

Accession 0001501697-25-000035

CIK 0001501697other

View on SEC.gov Company Profile

Filed

Oct 26, 8:00 PM ET

Accepted

Oct 27, 6:40 PM ET

Size

4.9 KB

Accession

0001501697-25-000035

Insider Transaction Report

Form 4

Period: 2025-10-23

X4 Pharmaceuticals, IncXFOR

DirectorExecutive Chairman

Transactions

Purchase
Common Stock
2025-10-23$2.90/sh+86,206$249,997→ 376,087 total

Footnotes (1)

[F1]Consists of shares of the Issuer's common stock purchased in connection with the Issuer's public offering.

Documents

1 file

4
wk-form4_1761604837.xmlPrimary
FORM 4

Issuer

X4 Pharmaceuticals, Inc

CIK 0001501697

Entity typeother

Related Parties

1

filerCIK 0001339498

Filing Metadata

Form type: 4
Filed: Oct 26, 8:00 PM ET
Accepted: Oct 27, 6:40 PM ET
Size: 4.9 KB

View on SEC.gov